Viewing Study NCT00561067


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2026-02-22 @ 6:46 PM
Study NCT ID: NCT00561067
Status: TERMINATED
Last Update Posted: 2019-03-14
First Post: 2007-11-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study Versus Methylprednisolone (MP)
Sponsor: Niguarda Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Spinal Cord Injury View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Spinal cord injury View
None spinal shock View
None erythropoietin View